Search results for "FDA update"

Results 21 - 30 of about 100 for "FDA update".

Olmesartan passes safety review | ACP Diabetes Monthly

The benefits of the angiotensin-receptor blocker olmesartan continue to outweigh the risks for diabetic patients, according to the FDA.

FDA urges patients to use caution when injecting insulin with pen needles | ACP Diabetes Monthly

The agency offered new recommendations after receiving reports of patients using standard pen needles to inject insulin without removing the inner needle cover.

Aflibercept approved for diabetic retinopathy in diabetic macular edema | ACP Diabetes Monthly

Aflibercept (Eylea) has received expanded approval to treat diabetic retinopathy (DR) in patients with diabetic macular edema (DME), the FDA recently announced.

Saxagliptin under analysis for heart failure risk | ACP Diabetes Monthly

The FDA has requested clinical trial data on saxagliptin (Onglyza and Kombiglyze XR) to investigate a possible increase in heart failure in patients taking the drug.

Abbot FreeStyle Insulinx meters recalled | ACP Diabetes Monthly

The Abbott FreeStyle Insulinx blood glucose meters were recently recalled because at extremely high blood glucose levels of 1,024 mg/dL and above, the meters will display and store in memory an incorrect test result that is 1,024 mg/dL below the

New daily injection approved for adults with type 2 diabetes | ACP Diabetes Monthly

Lixisenatide (Adlyxin), a once-daily injection, was approved by the FDA on July 28 to improve glycemic control in adults with type 2 diabetes.

New weight loss drug approved | ACP Diabetes Monthly

Lorcaserin hydrochloride (Belviq) was recently approved by the FDA for chronic weight management in adults.

Inhaled insulin approved | ACP Diabetes Monthly

Afrezza, a rapid-acting, inhaled human insulin, was recently approved by the FDA to treat diabetes in adults.

New weight loss device approved | ACP Diabetes Monthly

A new balloon device (the ReShape Dual Balloon) was recently approved by the FDA to treat obesity without invasive surgery.

New labels warn against sharing multi-dose insulin pens | ACP Diabetes Monthly

In an effort to reduce the risk of infection spread, the FDA recently required additional label warnings about sharing of multi-dose diabetes pen devices, which are intended for single patient use only.

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next